Fatal anaphylactoid reaction following ioversol administration.
We report a fatal intravenous ioversol administration in a 60-year old male patient. Although the introduction of new low-osmolar non-ionogenic contrast media with a more favourable efficacy-toxicity balance has diminished the side-effects significantly, everyone involved in radiodiagnostic procedures should be aware of the potential life-threatening effects. Especially patients with risk factors for side-effects should be monitored carefully.
Jansman
Frank Ga
FG
Department of Clinical Pharmacy, Isala klinieken, Zwolle, The Netherlands. f.g.a.jansman@isala.nl
Kieft
Hans
H
Harting
Johannes W
JW
D000707:Anaphylaxis / Q000139:chemically induced*; D003287:Contrast Media / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C054871:ioversol